Telmisartan NDC 65862-869

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-869Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0869Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-869-03	65862086903	3 BLISTER PACK in 1 CARTON (65862-869-03) / 10 TABLET in 1 BLISTER PACK (65862-869-10)Marketed from Sep 3, 2015
65862-869-30	65862086930	30 TABLET in 1 BOTTLE (65862-869-30)Marketed from Jun 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Telmisartan
Generic name (nonproprietary): telmisartan
Active ingredients: Telmisartan — 80 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206511
Marketing start: Sep 3, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 65862-869_eea7e7a7-9c01-4097-8e5c-ab1ad574acc8SPL ID eea7e7a7-9c01-4097-8e5c-ab1ad574acc8SPL set ID fef6532d-438a-435e-a61f-216dd8551339RxCUI 205304, 205305, 282755UNII U5SYW473RQ
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862086903 followed by a unit qualifier and the quantity

Package 65862-0869-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 19, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Telmisartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors ( 1.2 ) 1.1 Hypertension Telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of ph…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206511

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206511
Product	Strength	Form · route	Labeler	Product NDC
Telmisartan	Telmisartan 40 mg/1	TabletOral	Aurobindo Pharma Limited	65862-868
Telmisartan	Telmisartan 20 mg/1	TabletOral	Aurobindo Pharma Limited	65862-867